Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Type B insulin resistance syndrome coexisting with aplastic anemia responsive to early immunosuppressive therapy.

JCEM case reports·2026

Same author

Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot Trial.

Marine drugs·2026

Same author

The Prognostic Value of Circulating Tumor DNA for Clinical Outcomes in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis.

International journal of molecular sciences·2026

Same author

Low FXIII activity levels in patients with vascular anomalies, not in patients with trauma-induced coagulopathy.

PloS one·2026

Same author

Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.

American journal of hematology·2026

Same author

Ninjin'yoeito for Impaired Oral Function in Older Adults: A Prospective, Open-Label Pilot Study.

Medicina (Kaunas, Lithuania)·2026

Search research articles

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Molecular Immunology in Hematological Disorders.

Akiyoshi Takami¹

¹Department of Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.

International Journal of Molecular Sciences

|September 9, 2022

Summary

This Special Issue explores the molecular mechanisms driving blood cancers like leukemia, lymphoma, and myeloma. Understanding these pathways is key to developing targeted therapies for hematologic malignancies.

Area of Science:

Hematology
Molecular Biology
Oncology

Background:

Hematologic malignancies encompass a range of blood cancers including leukemia, lymphoma, and myeloma.
The development and progression of these diseases are complex processes.
Understanding the underlying molecular mechanisms is crucial for effective treatment strategies.

Discussion:

This issue focuses on the intricate molecular pathways implicated in the pathogenesis of blood cancers.
Key areas include genetic mutations, epigenetic alterations, and signaling pathway dysregulation.
The insights presented aim to bridge the gap between basic research and clinical application.

Key Insights:

Detailed exploration of molecular drivers in leukemia, lymphoma, and myeloma.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

Identification of novel therapeutic targets based on mechanistic understanding.

Emphasis on the heterogeneity of hematologic malignancies at the molecular level.

Outlook:

Future research directions in understanding blood cancer biology.
Potential for novel diagnostic and prognostic biomarkers.
Advancements in targeted therapies and personalized medicine for hematologic malignancies.